Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. K.C. Pharmaceuticals, Inc
FDA Inspection
•K.C. Pharmaceuticals, Inc•August 28, 2024

K.C. Pharmaceuticals, Inc – FDA Inspection, Aug 28, 2024

Record Details

This FDA Inspection record concerns K.C. Pharmaceuticals, Inc, with an inspection on August 28, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
K.C. Pharmaceuticals, Inc
Inspection Date
August 28, 2024
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Ana-Maria A. Plapcianu (FDA Associated Person)
  • Christopher R. Czajka (FDA Associated Person)
  • Ngozi G. Offor (Company Rep)
View Company Profile

ID · 4d2997fd-981a-47b9-b559-199031f88ad1

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1247201
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

6
  1. 21 CFR 211.122(d)Label storage access limited to authorized personnel
  2. 21 CFR 211.194(a)(8)Second person sign off
  3. 21 CFR 211.113(b)Validation lacking for sterile drug products
  4. 21 CFR 211.22(d)Procedures not in writing, fully followed
  5. 21 CFR 211.166(a)Written program not followed
  6. 21 CFR 211.100(a)Absence of Written Procedures

Full citation text and observation details available on the Dashboard.

Other FDA inspections of K.C. Pharmaceuticals, Inc

10
DateClassificationOfficeProject area
February 13, 2026Not classifiedLos Angeles District OfficeDrug Quality Assurance
February 13, 2023OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
January 30, 2020VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 16, 2017VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
March 19, 2015VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 10 other inspections on the company page
Other documents for K.C. Pharmaceuticals, Inc
  • FDA Inspection 1294070 - 2026-02-13
  • FDA Inspection 1197242 - 2023-02-13
  • FDA Inspection 1116341 - 2020-01-30
  • FDA Inspection 1032267 - 2017-11-16
  • FDA Inspection 923526 - 2015-03-19

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore K.C. Pharmaceuticals, Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.